Trial intelligence / Profile preview

Losartan for Prevention of Sodium Retention and Ascites in Liver Cirrhosis

NCT00239096Phase 4Unknown

Sponsor
University Hospital Odense
Start
Sep 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of losartan in alcoholic liver cirrhosis, ascites, sponsored by University Hospital Odense. Status: unknown.

02

Drugs

losartan
03

Conditions

alcoholic liver cirrhosisascites

Beyond the preview

Go deeper on NCT00239096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00239096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call